4//SEC Filing
HAUMANN BRETT K 4
Accession 0001179110-20-009263
CIK 0001583107other
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 6:21 PM ET
Size
6.3 KB
Accession
0001179110-20-009263
Insider Transaction Report
Form 4
HAUMANN BRETT K
SVP, Clinical Development
Transactions
- Sale
Ordinary Shares
2020-08-21$18.29/sh−25,000$457,240→ 282,810 total - Tax Payment
Ordinary Shares
2020-08-20$18.22/sh−4,646$84,650→ 307,810 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices from $18.22 to $18.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001607733
Filing Metadata
- Form type
- 4
- Filed
- Aug 23, 8:00 PM ET
- Accepted
- Aug 24, 6:21 PM ET
- Size
- 6.3 KB